dc.contributor.author | Lisboa, Thiago | |
dc.contributor.author | Salluh, Jorge | |
dc.contributor.author | Povoa, Pedro | |
dc.date.accessioned | 2021-07-08T18:46:49Z | |
dc.date.available | 2021-07-08T18:46:49Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | LISBOA, T.; SALLUH, J.; POVOA, P. Do we need new trials of procalcitoninguided antibiotic therapy? Critcal Care, v. 22, n. 17, p. 1-3, 2018. Disponível em: http://hdl.handle.net/11690/1776. Acesso em: 08 jul. 2021. | pt_BR |
dc.identifier.uri | http://hdl.handle.net/11690/1776 | |
dc.language.iso | en_US | pt_BR |
dc.publisher | BioMed Central | pt_BR |
dc.rights | Open Access | en |
dc.subject | Uso de biomarcadores | pt_BR |
dc.subject | Infecções respiratórias | pt_BR |
dc.title | Do we need new trials of procalcitoninguided antibiotic therapy? | pt_BR |
dc.type | Artigo | pt_BR |